Status:
NOT_YET_RECRUITING
Impact of Kolcaba Comfort Theory Training on Dyspnea, Function, and Comfort in COPD Patients
Lead Sponsor:
Ataturk University
Collaborating Sponsors:
Scientific Research Projects Coordination Unit
Conditions:
Main Heading (Descriptor) Terms
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is the third most fatal chronic disease worldwide, following cardiovascular diseases and cancer. COPD is characterized by chronic respiratory symptoms due ...
Eligibility Criteria
Inclusion
- Be 18 years of age or older.
- Have been diagnosed with COPD for at least 6 months.
- Be in GOLD stages 1, 2, or 3 of COPD.
- Be able to read and write in Turkish.
- Have access to a phone for communication.
Exclusion
- Patients experiencing an acute exacerbation.
- Presence of non-COPD pulmonary problems or diagnosed cardiovascular diseases.
- Psychiatric disorders that disrupt thought processes, such as dementia or schizophrenia.
- Respiratory issues caused by diseases other than COPD.
- Problems with communication or speech.
- Use of a respiratory exercise device (PEP).
- Inability to tolerate PEP use.
- Desire to withdraw from the study at any point.
Key Trial Info
Start Date :
September 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 10 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06588361
Start Date
September 10 2024
End Date
June 10 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ataturk University
Erzurum, Turkey (Türkiye)